About this trial
The goal of this pilot feasibility study is to evaluate a wearable microwave (MW)-based bladder monitoring system in adult volunteers and those with spinal cord injury (SCI) who use self-catheterization for bladder management. The study aims to learn whether the device can monitor bladder filling and estimate bladder volume non-invasively.
The main questions the study aims to answer are:
1. Can the MW-based monitoring system distinguish between non-full and full bladder states? 2. How accurately do MW-based bladder volume estimates agree with ultrasound bladder scans and voided urine volumes? 3. Is the wearable monitoring system feasible, comfortable, and usable for individuals with SCI?
Participants will:
1. Complete questionnaires about bladder symptoms and quality of life 2. Wear up to six non-invasive MW sensors on the lower pelvic region 3. Undergo two bladder filling and voiding cycles during the study visit 4. Have MW measurements collected approximately every five minutes during bladder filling 5. Undergo ultrasound bladder scans and bladder volume measurements for comparison 6. Complete a post-study usability and comfort survey
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age > 18
Able/willing to sit (or stand) in place for the time it takes for bladder to fill once.
No implanted devices
Able to toilet/void independently
Disqualifiers
Age < 18
Implanted devices (e.g., pacemakers)
Unable to toilet without assistance
Unable to stay relatively still for the time it takes bladder to fill once
Trial design
Single group
Treatments tested in this trial
Wearable microwave Bladder Monitoring System
DeviceThe investigational device is a non-invasive wearable microwave (MW) bladder monitoring system designed to monitor bladder filling and estimate bladder volume. The system uses low-power radio-frequency (RF) signals and externally applied sensors positioned over the lower pelvic region to collect electromagnetic measurements associated with bladder filling. Measurements will be collected approximately every five minutes during natural bladder filling cycles. The device is intended for investigational use only and does not provide therapeutic intervention or automated clinical decision-making.
Treatment groups
Trial outcomes
Primary outcomes
Mean difference in microwave S-parameter magnitude between full and empty bladder states (dB)
Microwave S-parameter measurements collected during bladder filling and voiding cycles will be compared between empty and full bladder states. The outcome will be reported as the mean difference and standard deviation in S-parameter magnitude between full and empty bladder states across the measured frequency range, expressed in decibels (dB).
Mean error of microwave-based bladder volume estimation (mL) relative to ultrasound bladder volume estimates and voided urine volume
Bladder volume estimates derived from microwave S-parameter measurements will be compared with ultrasound bladder volume estimates and voided urine volumes obtained during bladder filling and voiding cycles. The outcome will be reported as the mean difference and standard deviation between microwave-based bladder volume estimates and the corresponding reference measurements (mL).
Secondary outcomes
Total score on the investigator-developed post-participation bladder monitor questionnaire
Participant perceptions of comfort, usability, and utility of the wearable microwave-based bladder monitoring system will be assessed using an investigator-developed post-participation questionnaire. Total scores range from 1 to 10, with higher scores indicating greater comfort, usability, and perceived utility of the device.
Frequency points exhibiting the greatest difference in microwave S-parameter magnitude between full and empty bladder states (MHz)
For each participant, differences in microwave S-parameter magnitude between full and empty bladder states will be calculated across the 500-3000 MHz frequency range. The outcome will identify the frequency points and frequency ranges exhibiting the largest bladder-state-dependent signal differences. Analyses will be performed for the overall cohort and separately for male and female participants to assess sex-based differences in optimal frequency selection.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead sponsor
Congressionally Directed Medical Research Programs
Collaborator
This trial is not recruiting at the moment. You can still explore other options: